Rocio Salas-Whalen

Join Dr. Rocio Salas-Whalen, a triple board certified endocrinologist, as she dives into the complexities of obesity and weight loss treatments. They discuss the truth about GLP-1 medications like Ozempic, including their effects on appetite and cravings. Dr. Salas-Whalen emphasizes that obesity isn't a personal failure and explains the five causes of weight gain, many of which are beyond individual control. She also shares her personal experiences with weight management during perimenopause, offering insights for women navigating similar challenges.

Dr. Rocio Salas-Whalen, a triple board-certified endocrinologist and founder of New York Endocrinology, shares insights into the effects of GLP-1 medications on weight loss and menopause. She highlights the overlooked mental and physical changes post-weight loss and emphasizes the importance of the maintenance phase. Dr. Salas-Whalen also discusses the cost crisis surrounding GLP-1s, the psychological impacts of rapid weight loss, and the necessity of therapy for emotional support. Her expertise includes handling emerging treatments and ensuring effective patient care.

Dr. Rocio Salas-Whalen, a triple board-certified internist and founder of New York Endocrinology, joins the conversation to discuss GLP-1 medications and their impact on midlife women. She explains how these drugs redefine obesity treatment as a chronic condition influenced by hormones and metabolism. The discussion dives into why estrogen decline leads to weight gain and abdominal fat, how GLP-1s can help, and the significance of preserving muscle mass during weight loss. Dr. Salas-Whalen also introduces her GPS protocol, combining GLP-1s with protein and strength training.

Dr. Rocio Salas-Whalen, a triple board-certified endocrinologist and obesity medicine expert, shares her insights on the groundbreaking GLP-1 therapies. She discusses how these medications can combat obesity, reduce inflammation, and potentially lower Alzheimer's and cancer risks. Dr. Salas-Whalen also explores the connection between estrogen, menopause, and weight gain, emphasizing a shift in patient goals from appearance to strength. Tune in for her take on the future of GLP-1 innovations and her upcoming book, 'Weightless.'

Dr. Rocio Salas-Whalen discusses the science behind Ozempic injections for weight loss. They explore the use of FDA-approved medications for weight loss, the benefits of weight loss maintenance medication, and the side effects and risks associated with these medications. They also touch on the concerns of off-label usage, the need for FDA regulation of supplements, and the importance of prioritizing patient health.

Dr. Rocio Salas-Whalen, owner of New York Endocrinology and a renowned expert in diabetes and obesity, dives into the evolving understanding of obesity as a chronic disease. She discusses its complex ties to type 2 diabetes and the rising awareness post-COVID-19. The conversation highlights groundbreaking GLP-1 and GIP medications that reshape the weight loss landscape, discussing their benefits and psychological impacts on food cravings. Dr. Salas-Whalen also addresses the challenges posed by insurance companies in treating obesity, pushing for a more proactive medical approach.

Dr. Rocio Salas-Whalen, a board-certified endocrinologist and obesity medicine specialist, delves into the surprising benefits of GLP-1 medications beyond appetite suppression. She discusses their impact on fertility, inflammation, and even addictive behaviors, reshaping our understanding of metabolic and hormonal health. Dr. Salas-Whalen emphasizes the importance of body composition over BMI and shares insights on how muscle serves as an anti-inflammatory powerhouse. Get ready for a mind-opening conversation on holistic health and the future of weight management!

Dr. Rocio Salas-Whalen, a double board-certified endocrinologist and obesity medicine expert, dives into the impact of estrogen decline on weight and muscle in midlife. She clarifies misconceptions about GLP-1 medications, detailing who truly benefits from them. The discussion touches on the hidden dangers of 'skinny fat' and the necessity of focusing on body composition rather than BMI. Dr. Rocio also addresses the psychological challenges of food cravings and how GLP-1s can help promote healthier eating habits for lasting change.

This conversation features Dr. Mary Claire Haver, an expert in midlife women's health, Dr. Rocio Salas-Whalen, who specializes in obesity medicine, and Physician Assistant McCall McPherson, focusing on thyroid care. They delve into how inflammation affects weight gain and share strategies like macronutrient timing and strength training. The benefits of GLP-1 drugs for appetite control and muscle preservation are discussed, along with essential labs to monitor metabolic health. Prioritizing self-care and adapting nutrition is also emphasized for long-term wellness.

Rocío Salas-Whalen, M.D., a board-certified endocrinologist and an expert in GLP-1 therapies, dives into the crucial link between muscle mass and metabolism. She emphasizes that muscle loss poses greater health risks than excess fat. Rocío discusses the benefits of GLP-1s, when they're appropriate, and highlights the importance of protein and strength training in preserving muscle on these medications. She also addresses common misconceptions and the role of mindset in achieving long-term health goals, particularly in the context of obesity and lifestyle changes.